Literature DB >> 28521378

[Studies in Rare Diseases: A Descriptive Analysis of Completed Orphan Drug Benefit Assessments at the Federal Joint Committee].

Sandra Schulz1, Anna Passon1, Michael Kulig1, Matthias Perleth1, Katja Matthias1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28521378     DOI： 10.1055/s-0043-104696

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN： 0941-3790


× No keyword cloud information.
  1 in total

1.  The Evaluation of Orphan Drugs by the German Joint Federal Committee-An Eight-Year Review.

Authors:  Sandra Schulz; Anna Marie Passon; Matthias Perleth; Michael Kulig; Nina Paschke; Katja Matthias
Journal:  Dtsch Arztebl Int       Date:  2020-12-11       Impact factor: 5.594
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.